The differential effect of statins on oxidative stress and endothelial function: Atorvastatin versus pravastatin

Journal of Clinical Lipidology

Volumn 6, Issue 1, 2012, Pages 42-49

  Murrow, Jonathan R ^a   Sher, Salman ^a   Ali, Sarfraz ^a   Uphoff, Irina ^a   Patel, Riyaz ^a   Porkert, Marcus ^a   Le, Ngoc Anh ^a   Jones, Dean ^a   Quyyumi, Arshed A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial function; Metabolic syndrome; Oxidative stress; Statins

Indexed keywords

AMINOTHIOL; ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG POTENCY; ENDOTHELIUM CELL; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTICHOLESTEREMIC AGENTS; BRACHIAL ARTERY; CYSTINE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; GLUTATHIONE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; PRAVASTATIN; PYRROLES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TREATMENT OUTCOME; VASODILATION;

EID: 84856225815     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.08.006     Document Type: Article

References (32)

1. S. Furukawa, T. Fujita, and M. Shimabukuro Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 2004 1752 1761 (Pubitemid 40385531)
2. P. Deedwania, P. Barter, and R. Carmena Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study Lancet 368 2006 919 928 (Pubitemid 44331360)
3. J. Davignon Beneficial cardiovascular pleiotropic effects of statins Circulation 109 2004 III39 III43
4. K. Yasunari, K. Maeda, M. Minami, and J. Yoshikawa HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress Arterioscler Thromb Vasc Biol 21 2001 937 942 (Pubitemid 34168649)
5. J.M. McCord The evolution of free radicals and oxidative stress Am J Med 108 2000 652 659 (Pubitemid 30336605)
6. S. Tsimikas Measures of oxidative stress Clin Lab Med 26 2006 571 590 v-vi (Pubitemid 44308368)
7. S. Ashfaq, J.L. Abramson, and D.P. Jones Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults Hypertension 52 2008 80 85
8. B. Ky, A. Burke, and S. Tsimikas The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans J Am Coll Cardiol 51 2008 1653 1662 (Pubitemid 351626406)
9. M.H. Shishehbor, M.L. Brennan, and R.J. Aviles Statins promote potent systemic antioxidant effects through specific inflammatory pathways Circulation 108 2003 426 431 (Pubitemid 36935535)
10. M. Hsu, L. Muchova, I. Morioka, R.J. Wong, H. Schröder, and D.K. Stevenson Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo Biochem Biophys Res Commun 343 2006 738 744
11. S.E. Nissen, E.M. Tuzcu, and P. Libby Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial JAMA 292 2004 2217 2225
12. C.P. Cannon, E. Braunwald, and C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504 (Pubitemid 38477774)
13. I.T. Mak, and W.B. Weglicki Antioxidant activity of calcium channel blocking drugs Methods Enzymol 234 1994 620 630
14. D.P. Jones, J.L. Carson, V.C. Mody, J. Cai, M.J. Lynn, and P. Sternberg Redox state of glutathione in human plasma Free Radic Biol Med 28 2000 625 635 (Pubitemid 30136044)
15. A. Alberti, L. Bolognini, D. Macciantelli, and M. Caratelli The radical cation of N, N-diethyl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples Res Chem Intermed 26 2000 253 267
16. Cornelli U. CM, Terranova R. Free-radicals and vascular disease. IUA Bull. 1999;15:7-10.
17. M.R. Cesarone, G. Belcaro, and M. Caratelli A simple test to monitor oxidative stress Int Angiol 2 1999 127 130 (Pubitemid 29306588)
18. J.L. Abramson, W.C. Hooper, and D.P. Jones Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease Atherosclerosis 178 2005 115 121 (Pubitemid 39600823)
19. M.C. Corretti, T.J. Anderson, and E.J. Benjamin Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery1: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265 (Pubitemid 34084631)
20. R.S. Rosenson, and H.E. Bays Results of two clinical trials on the safety and efficacy of pravastatin 80 and 160 mg per day Am J Cardiol 91 2003 878 881 (Pubitemid 36363738)
21. S. Delliaux, J.G. Steinberg, and G. Bechis Statins alter oxidant-antioxidant status and lower exercise-induced oxidative stress Int J Clin Pharmacol Ther 45 2007 244 252 (Pubitemid 46629385)
22. M.K. Thomas, D. Narang, R. Lakshmy, R. Gupta, N. Naik, and S.K. Maulik Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals Cardiovasc Drugs Ther 20 2006 37 44
23. K. Sakabe, N. Fukuda, K. Wakayama, T. Nada, H. Shinohara, and Y. Tamura Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia Am J Cardiol 94 2004 497 500 (Pubitemid 39120004)
24. U. Singh, S. Devaraj, I. Jialal, and D. Siegel Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome Am J Cardiol 102 2008 321 325
25. S. Tsimikas In vivo markers of oxidative stress and therapeutic interventions Am J Cardiol 101 2008 34D 42D
26. A. Tamura, T. Watanabe, and M. Nasu Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients Circ J 67 2003 816 820 (Pubitemid 37229216)
27. M.F. Chen, H.C. Hsu, and Y.T. Lee Short-term treatment with low-dose pravastatin attenuates oxidative susceptibility of low-density lipoprotein in hypercholesterolemic patients Cardiovasc Drugs Ther 11 1997 787 793
28. A. Zhang, J. Vertommen, L. Van Gaal, and I. De Leeuw Effects of pravastatin on lipid levels, in vitro oxidizability of non-HDL lipoproteins and microalbuminuria in IDDM patients Diabetes Res Clin Pract 29 1995 189 194
29. S. Ashfaq, J.L. Abramson, and D.P. Jones The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults J Am Coll Cardiol 47 2006 1005 1011
30. S. Passi, A. Stancato, E. Aleo, A. Dmitrieva, and G.P. Littarru Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA Biofactors 18 2003 113 124 (Pubitemid 38030705)
31. P.A. Economides, A. Caselli, E. Tiani, L. Khaodhiar, E.S. Horton, and A. Veves The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes J Clin Endocrinol Metab 89 2004 740 747 (Pubitemid 38269887)
32. M. Sebestjen, M. Boh, and I. Keber Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia Wien Klin Wochenschr 114 2002 999 1003 (Pubitemid 36105545)